President, Head of Global Development, Oncology · Zai Lab Ltd (ZLAB)

Alan Sandler

FY2020 is the first fiscal year CompBrief holds for Alan Sandler as a named executive officer of Zai Lab; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$7,063,890

Salary $45,000Stock awards $3,267,900Bonus $500,000

2nd of 5 named executive officers at Zai Lab by FY2020 total.

5 named officers on file for Zai Lab, FY2020

Alan Sandler’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 2 equity grants, each cited to its filing
  • ZLAB’s disclosed peer group of 20 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Zai Lab’s whole pay program stands against its peers

  • Zai Lab’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ZLAB→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 30, 2021 (DEF 14A).

Free

Get Alan Sandler’s full pay file as a PDF — free

More than this page: up to 10 years of Alan’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Alan Sandler compensation by year

Zai Lab Summary Compensation Table · the one fiscal year held
In US dollars, as Zai Lab reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020
Salary$45,000
Bonus$500,000
Stock awards$3,267,900
Option awards$3,250,990
Non-equity incentive$0
Pension and deferred compensation$0
All other$0
Total$7,063,890

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Zai Lab Ltd DEF 14A filed April 30, 2021, accession 0001193125-21-144949, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Zai Lab Ltd filed document, accession 0001193125-21-144949. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2021.

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
RSU30,000$4,060,200—
Option47,000—$108.93

Per the Outstanding Equity Awards at Fiscal Year-End table in Zai Lab Ltd's FY2020 proxy; value at the fiscal year-end close, as the company printed it.

Zai Lab’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Ying DuChairwoman and Chief Executive Officer$8,536,036
Alan Sandler · this pagePresident, Head of Global Development, Oncology$7,063,890
Ty EdmondsonChief Legal Officer$4,408,928
Billy ChoChief Financial Officer$1,484,163
Tao FuPresident and Chief Operating Officer$649,770

The full Zai Lab compensation record

free company brief

This page is one person within Zai Lab's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Zai Lab's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Alan Sandler's compensation dossier · One-time report. No refunds.